- $5.76bn
- $1.19bn
- $56.87m
- 84
- 22
- 32
- 43
Annual income statement for QXO, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | R2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 41.2 | 41.7 | 45 | 54.5 | 56.9 |
Cost of Revenue | |||||
Gross Profit | 16.6 | 17.2 | 18 | 21.6 | 22.9 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 41 | 41.6 | 45.4 | 55.8 | 128 |
Operating Profit | 0.223 | 0.09 | -0.385 | -1.31 | -71 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 0.223 | 0.044 | -0.474 | -1.37 | 50.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | 0.176 | -0.134 | -0.282 | -1.07 | 28 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 0.176 | -0.134 | -0.282 | -1.07 | 28 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 0.176 | -0.134 | -0.282 | -1.07 | -23 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.312 | -0.546 | -0.437 | 1.33 | -0.071 |
Special Dividends per Share |